Key Takeaways
- Strong quarter, volume-led: Revenue grew 39.5% YoY, with approximately 85% of that growth coming from volume rather than price or mix.
- Profitability expanded sharply: PAT margin rose 326 bps to 19.5%, while EBITDA margin expanded 49 bps to 26.3% on cost discipline and operating leverage.
- Capacity is the binding constraint, and it is being lifted: Utilization ran at ~80% in Q1, with 4,500 tons of debottlenecking due this year and a ₹460 crore capex program targeting Q3 FY28 commissioning.
- Subsidiary drag is deliberate, not accidental: West African procurement entities and the Brazil build-out currently weigh on consolidated margins, but management frames these as funded investments that should turn contributive as they scale.
- What to watch next quarter: Whether the Brazil ramp-up shows quarter-on-quarter progress, whether the supplier debit note recovery materializes, and whether margins hold the guided broadly stable range.
Growth & Volume Dynamics
- Volume-led expansion: The 39% YoY revenue growth was driven overwhelmingly by volume, with management attributing roughly 85% of the increase to higher volumes rather than price or mix shifts.
- Pricing stability: Value-added product pricing remained largely stable and in line with the costing model, despite macro volatility, because products are formulated to customer specifications and recipes.
- Capacity utilization: The company operated at around 80% utilization in Q1 FY27, with full-year guidance of 80–85% on the expanded 52,000-ton base once debottlenecking lands around Q3.
- Gross margin context: Gross margin broadly moves in a 45–50% range, but management cautions against reading it in isolation because freight cost timing and by-product realization (de-oiled cake) create quarter-to-quarter noise; EBITDA margin is the better lens.
Ekta Soni: "Our products are more value-added product, which is formulated and based on certain specifications and recipes of the confectionery chocolate or cosmetics. So our pricing model, if you say, has been -- remained stable largely, which is in line of our costing model as well."
Capacity Expansion & Capex
- Debottlenecking underway: A portion of the additional 7,500-ton capacity is already operational, with the balance of 4,500 tons expected this financial year, taking total capacity from 47,500 to approximately 52,000 tons per annum.
- New capex program: The ₹460 crore proposed capex includes solvent fractionation capacity, refinery capacity in India, and a backward integration project (extraction and expelling) in Burkina Faso.
- Commissioning timeline: Both the Indian solvent fractionation and refinery projects and the Burkina Faso facility are tentatively targeted for commissioning around Q3 FY28, with gradual contribution from that period and fuller impact visible in FY29 as utilization ramps.
- FY27 capex spend: Ballpark guidance is approximately ₹225–250 crores for FY27, with ₹120–130 crores allocated to the Burkina Faso facility and the balance to Indian projects.
- Burkina Faso economics: The plant carries an expected payback period of around 3 years once operational and should meaningfully impact the bottom line and improve efficiency through backward integration.
- Funding posture: Working capital requirement of around 50% in terms of raw material is lined up with existing bankers, with State Bank of India as lead banker; no further equity dilution is planned in the near term.
Ashish Saraf: "We are steadily advancing our aspiration of becoming the partner of choice for the world's leading food and confectionery and cosmetic companies through strategic investments in research and development, sourcing, manufacturing and market expansion."
Margins & Cost Structure
- Margin expansion drivers: EBITDA margin expanded 49 bps to 26.3% on disciplined cost management, operational efficiencies, and operating leverage, while PAT margin expanded 326 bps to 19.5% on product mix optimization and capacity utilization.
- Employee cost normalization: Employee cost declined ~20% QoQ because Q4 FY26 included a performance incentive provision; the go-forward run rate is expected around ₹14–15 crores per quarter.
- Other expenses pressure: Other expenses jumped 16% QoQ primarily on higher freight and container costs, a reminder that logistics inflation remains a live variable.
- Margin outlook: Management guides for broadly stable underlying margins with modest quarter-to-quarter movement possible depending on mix and one-off items, while acknowledging that specific guidance is difficult.
- Operating leverage direction: As capacity expansion and product mix improvement progress, operating leverage should come into play and put margins on an improving trajectory, though management stops short of quantifying it.
Ekta Soni: "Margins can see modest quarter-to-quarter movement depending on mix and one-off items. But the underlying lens range is expected to hold broadly stable. At the same time, business is business. Business has risk also."
Subsidiaries & International Build-out
- West African entities: These are mostly cost procurement vehicles with no standalone revenue, so consolidation carries operating costs without corresponding top line; this quarter's costs are normal operational costs for entities at different stages of maturity, unlike Q4 FY26 which had one-time items.
- Brazil subsidiary: Trial production started last quarter, samples have been sent, and production has been dispatched from the Indian plant to the Brazilian entity for processing; management expects a gradual ramp-up over the next 2–4 quarters on a quarter-on-quarter basis.
- Brazil revenue guidance: Management declined to guide specific contribution until operations start meaningfully, but directionally sees a very good opportunity in that market.
- Chad subsidiary: Recently incorporated as a vehicle for sourcing shea nut and butter from the Africa region, extending the company's footprint to 10 wholly owned subsidiaries across Africa.
- Subsidiary drag trajectory: Management frames these as deliberate funded investments in long-term capability; as entities scale, their drag on consolidated margins should directionally reduce and over time turn into a contributor.
Ekta Soni: "These are deliberate funded investments in the long-term capability. And we see as these entities scale, directionally, their drag on consolidated margins should reduce and over time, turn into a contributor."
Product & Technology Initiatives
- CBA/ECBE product: The company is setting up technology to convert liquid fractions into solid fractions using enzymatic processes, creating an enzymatic cocoa butter equivalent (ECBE) for cocoa butter alternative applications in food, chocolate, confectioneries, and HoReCa.
- Forward integration logic: The CBA plant uses an interesterified process to make value-added products from coproducts and byproducts like olein, upgrading what would otherwise be lower-value liquid fractions.
- Burkina Faso land acquisition: Approximately 10 hectares (24 acres) have been purchased for the backward integration plant, with regulatory approvals still awaited.
- Africa sourcing resilience: The Nigeria export ban does not materially impact sourcing strategy because the company's presence across the Africa region is vast and substantial; going forward, the company will also import butter from Burkina Faso.
Ekta Soni: "Through a technology here in from India, from an ESOS plant, we will convert some of the oil liquid fractions into a hard fraction using some enzymes toward it. So that would convert our liquid fraction into solid fractions that will help convert into a cocoa butter alternative segment, which will be called ECBE, enzymatic cocoa butter equivalent."
Risk & Contingencies
- Supplier debit note: The company raised a debit note against a manufacturer/supplier and is claiming the full amount, with an exchange notification already filed; management is confident of recovery within a certain time but did not confirm whether the supplier has accepted liability.
- Supplier diversification: The company already has diversified suppliers for the material in question, importing from a couple of countries with different suppliers, so it is not currently dependent on that particular manufacturer.
- Geopolitical exposure: Management acknowledges indirect impact from geopolitical tensions through freight, logistics, and other macroeconomic channels, but argues that diversification across 30+ countries for supply and multiple sourcing geographies (Africa, Malaysia, Indonesia) should not materially impact sourcing strategies.
- Hedging policy: The company will continue its historical policy of hedging 50–60% of net exposure, and notes it is a natural hedge due to simultaneous imports and exports.
Ekta Soni: "We cannot say that it will not any way not impact us directly. But of course, there is an indirect impact, which is there in terms of freight, logistics or could be other macroeconomic impact could be there. But as a company, we always navigate it and balance it out on what possible ways we could do."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Debottlenecking completion | Additional 4,500 tons capacity, taking total to ~52,000 tons per annum | Around Q3 FY27 |
| Full-year utilization | 80–85% on expanded 52,000-ton base | FY27 |
| New capex commissioning | Solvent fractionation 3, refinery, and Burkina Faso backward integration plant | Around Q3 FY28 |
| FY27 capex spend | Approximately ₹225–250 crores | FY27 |
| Burkina Faso payback | ~3 years once operational | From commissioning |
| Employee cost run rate | ₹14–15 crores per quarter | Going forward |
| Brazil ramp-up | Gradual quarter-on-quarter ramp-up | Next 2–4 quarters |
| Supplier recovery | Full debit note amount claimed; confident of recovery | Within a certain time, per SEBI updates |
| Hedging policy | 50–60% of net exposure hedged | Continuing policy |
| Equity dilution | No further equity dilution planned | Near term |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Revenue growth | 39.5% YoY, crossing ₹400 crore quarterly revenue milestone for the first time |
| EBITDA | ₹106 crores |
| EBITDA margin | 26.3%, expanded 49 bps YoY |
| PAT | ₹79 crores, up 67.6% YoY |
| PAT margin | 19.5%, expanded 326 bps YoY |
| Capacity utilization | ~80% for Q1; full-year expected at 80% to 85% |
| CBE and stearin revenue contribution | 71.4% of revenue; CBE specifically 30%, balance stearin |
| Export share | 50% to 60% of revenue, consistent with 55% to 60% in 1Q FY25 |
| Volume growth contribution | ~85% of the 39% YoY revenue growth was volume-led |
| Gross margin range | 45% to 50%, broadly stable |
| Employee cost run rate | ₹14 crores to ₹15 crores per quarter expected going forward |
| Other income | ₹16 crores, of which ₹13 crores forex gain and ₹3 crores FDR income |
| Capex guidance FY27 | ₹225 crores to ₹250 crores |
| Debottlenecking capacity addition | 4,500 tons expected in FY27, taking capacity from 47,500 to ~52,000 tons per annum |
| Burkina Faso plant payback | ~3 years once operational |